Publicação
Characterization of Liquid Dosage Forms of Atenolol and Enalapril Maleate for Oral and Enteral Feeding Administration
| dc.contributor.author | Mota, Sandra | |
| dc.contributor.author | Torres, Ana | |
| dc.contributor.author | Quintas, Clara | |
| dc.contributor.author | Peres, António M. | |
| dc.contributor.author | Ferreiro, Nuno Manuel | |
| dc.contributor.author | Cruz, Rebeca | |
| dc.contributor.author | Ferreira, Helena | |
| dc.contributor.author | Almeida, Isabel F. | |
| dc.contributor.author | Casal, Susana | |
| dc.date.accessioned | 2024-10-21T13:52:30Z | |
| dc.date.available | 2024-10-21T13:52:30Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | The limited availability of pharmaceutical formulations tailored for cardiovascular diseases in both pediatric and geriatric populations generates the need for compounded dosage forms to guarantee precise dosing and medication adherence. This study aimed to analyze the physicochemical properties and stability of formulations of atenolol and enalapril maleate prepared with a proprietary oral vehicle, SuspendIt®. To this end, palatability, injectability, pH, rheological behavior, and physical, microbiological, and chemical stability over a 180-day storage period at 25 ◦C and 5 ◦C were evaluated. Injectability tests confirmed the suitable use of both formulations for administration through enteral feeding tubes. By using a potentiometric electronic tongue, it was confirmed that the SuspendIt® vehicle effectively served as a bitter-blocking strategy for atenolol and enalapril maleate. Adequate stability throughout the storage period was confirmed in terms of the mechanical properties, pH, and effectiveness of the preservative system. The atenolol concentration remained above 90% of the initial amount, while the concentration of enalapril maleate decreased to 88% after 90 days of storage at 25 ◦C. In summary, the atenolol formulation maintained suitable chemical, physical, and microbiological stability after 180 days at both storage temperatures, while the enalapril maleate formulation remained stable up to 60 days at 25 ◦C and for 180 days at 5 ◦C. | pt_PT |
| dc.description.sponsorship | The authors received support and help fromthe Foundation for Science and Technology (FCT, Portugal) by national funds FCT/MCTES (PIDDAC) to Associate Laboratory Institute for Health and Bioeconomy—i4HB (DOI 10.54499/LA/P/0140/2020), to Research Unit on AppliedMolecular Biosciences—UCIBIO (DOI 10.54499/UIDB/04378/2020 and DOI 10.54499/UIDP/04378/2020), to CIMO (UIDB/00690/2020, https://doi.org/10.54499/UIDB/00690/2020; and UIDP/00690/2020, https://doi.org/10.54499/UIDP/00690/2020), toLASusTEC(LA/P/0007/2020) andtoLAQV-REQUIMTE (DOI 10.54499/LA/P/0008/2020,DOI 10.54499/UIDP/50006/2020 andDOI 10.54499/UIDB/50006/2020). Nuno Ferreiro acknowledges the Ph.D. research grant (2022.10072.BD) provided by FCT. Rebeca Cruz is gratefully supported by FCT (2022.00965.CEECIND). S.Mota acknowledges her Ph.D. research grant (2022.12487.BD) and A. Torres also acknowledges her Ph.D. research grant (2023.03685.BD), both fully supported by FCT. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Mota, Sandra; Torres, Ana; Quintas, Clara; Peres, António M.; Ferreiro, Nuno; Cruz, Rebeca; Ferreira, Helena; Almeida, Isabel F.; Casal, Susana (2024). Characterization of Liquid Dosage Forms of Atenolol and Enalapril Maleate for Oral and Enteral Feeding Administration. Pharmaceuticals. ISSN 1424-8247. 17:8, p. 1-25 | pt_PT |
| dc.identifier.doi | 10.3390/ph17081052 | pt_PT |
| dc.identifier.issn | 1424-8247 | |
| dc.identifier.uri | http://hdl.handle.net/10198/30474 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | MDPI | pt_PT |
| dc.relation | Applied Molecular Biosciences Unit | |
| dc.relation | Applied Molecular Biosciences Unit | |
| dc.relation | Mountain Research Center - UIDB/00690/2020 | |
| dc.relation | Mountain Research Center - UIDP/00690/2020 | |
| dc.relation | Associate Laboratory for Sustainability and Tecnology in Mountain Regions - LA/P/0007/2020 | |
| dc.relation | Associated Laboratory for Green Chemistry - Clean Technologies and Processes | |
| dc.relation | Associated Laboratory for Green Chemistry - Clean Technologies and Processes | |
| dc.relation | Associated Laboratory for Green Chemistry - Clean Technologies and Processes | |
| dc.relation | Extra virgin olive oil shelf-life prediction based on an integrated approach from farm to fork | |
| dc.relation | OXIGUT - OXIdized lipids and GUT balance: Finding sustainable solutions to protect food lipids and to improve human nutrition and health. | |
| dc.relation | Multi-Strategies to Improve Sustainability in the Cosmetic Product Life Cycle | |
| dc.relation | Topical treatment of rare forms of ichthyosis targeting disease pathophysiology | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
| dc.subject | Stability | pt_PT |
| dc.subject | Compounding | pt_PT |
| dc.subject | Oral formulations | pt_PT |
| dc.subject | Atenolol | pt_PT |
| dc.subject | Enalapril maleate | pt_PT |
| dc.subject | Enteral feeding | pt_PT |
| dc.subject | Liquid dosage forms | pt_PT |
| dc.title | Characterization of Liquid Dosage Forms of Atenolol and Enalapril Maleate for Oral and Enteral Feeding Administration | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.awardNumber | UIDB/04378/2020 | |
| oaire.awardNumber | UIDP/04378/2020 | |
| oaire.awardNumber | UIDB/00690/2020 | |
| oaire.awardNumber | UIDP/00690/2020 | |
| oaire.awardNumber | LA/P/0007/2020 | |
| oaire.awardNumber | LA/P/0008/2020 | |
| oaire.awardNumber | UIDP/50006/2020 | |
| oaire.awardNumber | UIDB/50006/2020 | |
| oaire.awardNumber | 2022.10072.BD | |
| oaire.awardNumber | 2022.00965.CEECIND/CP1724/CT0016 | |
| oaire.awardNumber | 2022.12487.BD | |
| oaire.awardNumber | 2023.03685.BD | |
| oaire.awardTitle | Applied Molecular Biosciences Unit | |
| oaire.awardTitle | Applied Molecular Biosciences Unit | |
| oaire.awardTitle | Mountain Research Center - UIDB/00690/2020 | |
| oaire.awardTitle | Mountain Research Center - UIDP/00690/2020 | |
| oaire.awardTitle | Associate Laboratory for Sustainability and Tecnology in Mountain Regions - LA/P/0007/2020 | |
| oaire.awardTitle | Associated Laboratory for Green Chemistry - Clean Technologies and Processes | |
| oaire.awardTitle | Associated Laboratory for Green Chemistry - Clean Technologies and Processes | |
| oaire.awardTitle | Associated Laboratory for Green Chemistry - Clean Technologies and Processes | |
| oaire.awardTitle | Extra virgin olive oil shelf-life prediction based on an integrated approach from farm to fork | |
| oaire.awardTitle | OXIGUT - OXIdized lipids and GUT balance: Finding sustainable solutions to protect food lipids and to improve human nutrition and health. | |
| oaire.awardTitle | Multi-Strategies to Improve Sustainability in the Cosmetic Product Life Cycle | |
| oaire.awardTitle | Topical treatment of rare forms of ichthyosis targeting disease pathophysiology | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04378%2F2020/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F04378%2F2020/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F00690%2F2020/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F00690%2F2020/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/LA%2FP%2F0007%2F2020/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/LA%2FP%2F0008%2F2020/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F50006%2F2020/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F50006%2F2020/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/POR_NORTE/2022.10072.BD/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/CEEC IND5ed/2022.00965.CEECIND%2FCP1724%2FCT0016/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/POR_NORTE/2022.12487.BD/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT//2023.03685.BD/PT | |
| oaire.citation.endPage | 25 | pt_PT |
| oaire.citation.issue | 8 | pt_PT |
| oaire.citation.startPage | 1 | pt_PT |
| oaire.citation.title | Pharmaceuticals | pt_PT |
| oaire.citation.volume | 17 | pt_PT |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| oaire.fundingStream | POR_NORTE | |
| oaire.fundingStream | CEEC IND5ed | |
| oaire.fundingStream | POR_NORTE | |
| person.familyName | Peres | |
| person.givenName | António M. | |
| person.identifier | 107333 | |
| person.identifier.ciencia-id | CF16-5443-F420 | |
| person.identifier.orcid | 0000-0001-6595-9165 | |
| person.identifier.rid | I-8470-2012 | |
| person.identifier.scopus-author-id | 7102331969 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | 7d93be47-8dc4-4413-9304-5b978773d3bb | |
| relation.isAuthorOfPublication.latestForDiscovery | 7d93be47-8dc4-4413-9304-5b978773d3bb | |
| relation.isProjectOfPublication | 4041d84e-441e-4181-833e-5049b6e09002 | |
| relation.isProjectOfPublication | 4f74fa67-8f04-40b2-bd32-03c7bf183db0 | |
| relation.isProjectOfPublication | 29718e93-4989-42bb-bcbc-4daff3870b25 | |
| relation.isProjectOfPublication | 0aac8939-28c2-46f4-ab6b-439dba7f9942 | |
| relation.isProjectOfPublication | 6255046e-bc79-4b82-8884-8b52074b4384 | |
| relation.isProjectOfPublication | ffe7aee6-d4fb-4ab0-942c-7c953636d735 | |
| relation.isProjectOfPublication | 5b103ed9-66ed-4343-93cf-fcdc042b9e79 | |
| relation.isProjectOfPublication | 0d71ca47-dd95-4204-8a34-d28377654df3 | |
| relation.isProjectOfPublication | b38c50e4-c3e2-4916-92ff-5419eaf88844 | |
| relation.isProjectOfPublication | 1f0a88c3-a656-4704-97fd-9d97533dc2a9 | |
| relation.isProjectOfPublication | 41b28a65-3519-47f4-af5a-6d55dfac80d4 | |
| relation.isProjectOfPublication | 542556c8-628c-48ad-99c5-830fa1c1aa6e | |
| relation.isProjectOfPublication.latestForDiscovery | 41b28a65-3519-47f4-af5a-6d55dfac80d4 |
